bullish
APAC Healthcare Weekly (Mar 9)- Daiichi Sankyo, Kyorin Pharma, Celltrion, Zydus Lifesciences, Biocon
545 Views09 Mar 2025 00:30
APAC healthcare companies continued to get approvals for new products and initiates clinical trials. The companies continued with acquisitions and collaborations to strengthen market position.
What is covered in the Full Insight:
- Daiichi Sankyo and Gastric Cancer Trial Results
- Kyorin Pharma's Global License Agreement with Novartis
- Celltrion’s Biosimilar Approvals and Market Availability
- Indian Pharmaceutical Market Growth and Top Products
- FDA Approvals and Strategic Moves by Biocon and Zydus
SUMMARY
(Sign Up to Access)Full Insight
(Paid Plans Only, 5-minute read)
Related Insights
More »Trending Collections
More »Trending Insights
More »- Hanwha Ocean (042660 KS) Placement: Index Implications; Stock Appears Wildly Overvalued
- Amara (AMA SP): Teo Family Reloads At S$0.895/Share
- Mazagon Dock Shipbuilders (MAZDOCKS IN): OFS & Potential Global Index Inclusion
- Toyota (7203 JP) Tactical Outlook Following Toyota Industries (6201 JP) Privatization Rumors
- Toyota Industries (6201) - SURPRISE! It's a TOYODA Takeover Proposal (Good Governance May Not Win)
Discussions
(Paid Plans Only)
- APAC Healthcare Weekly (Mar 30)- Eisai, Kaken, Mochida, Shionogi, SK Bioscience, PharmaEssentia30 Mar 2025
- APAC Healthcare Weekly (Mar 23)- Kissei, Alteogen, Junshi Biosciences, Celltrion, Lunit, HLB23 Mar 2025
- APAC Healthcare Weekly (Mar 16)- Celltrion, Ono Pharma, Sun Pharma, Syngene, Zydus, Sichuan Kelun16 Mar 2025
- APAC Healthcare Weekly (Mar 9)- Daiichi Sankyo, Kyorin Pharma, Celltrion, Zydus Lifesciences, Biocon09 Mar 2025
- APAC Healthcare Weekly (Mar 2)- Celltrion, Samsung Biologics, Biocon, Zydus Life, Healthcare Global02 Mar 2025
- APAC Healthcare Weekly (Feb 23)- Ono Pharma, Shionogi, Samsung Biologics, Celltrion, CSPC, Mayne23 Feb 2025
- APAC Healthcare Weekly (Feb 16)- Hansoh Pharma, Astellas Pharma, CSL, Imugene, LigaChem Bio, Lupin16 Feb 2025
x